CUSIP 28657F103COMELTXQ4 2025
18 filings · latest Oct 7, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 630.9K | $5.02M |
| 2 | Vanguard Group Inc | 496.9K | $3.96M |
| 3 | Balyasny Asset Management L.P. | 138.8K | $1.10M |
| 4 | Geode Capital Management, LLC | 132.5K | $1.06M |
| 5 | Marshall Wace, LLP | 117.2K | $932.9K |
| 6 | Susquehanna International Group, LLP | 64.1K | $509.9K |
| 7 | 683 Capital Management, LLC | 56.4K | $449.3K |
| 8 | Northern Trust Corp | 52.8K | $420.0K |
| 9 |
| 4 | Mar 7, 2025 | Yekaterina Chudnovsky | 13D/A | 48.1% | — | SEC |
| 5 | Feb 5, 2025 | Knoll Capital Management, LLC | 13G | 5.2% | 630.9K | SEC |
| 6 | Jan 7, 2025 | Actyus Private Equity Sgiic, S.A. | 13G | 5.5% | — | SEC |
| 7 | Aug 14, 2024 | Gkcc, LLC | 13D/A | 38.7% | 5.60M | SEC |
| 8 | Jul 2, 2024 | Gkcc, LLC | 13D/A | 20.0% | 2.15M | SEC |
| 9 | Apr 10, 2024 | Clal Biotechnology Industries Ltd. | 13D/A | 4.7% | 481.7K | SEC |
| 10 | Mar 20, 2024 | Clal Biotechnology Industries Ltd. | 13D/A | 5.8% | 599.2K | SEC |
See the full Schedule 13D/13G history for Elicio Therapeutics Inc.
Unlock full history| State Street Corp |
| 46.3K |
| $368.5K |
| 10 | Blackrock, Inc. | 45.2K | $359.6K |